Use of a continuous glucose monitor in the management of inoperable meta static insulinoma: A case report

Endocrine Practice

Volumn 14, Issue 7, 2008, Pages 880-883

  Sawyer, Alison M ^a   Schade, David S ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIAZOXIDE; DIURETIC AGENT; GLUCOSE; OCTREOTIDE;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY WARD; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULINOMA; LABORATORY DIAGNOSIS; LEG EDEMA; LIVER; LIVER METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY OF LIFE; RARE DISEASE; RECURRENT DISEASE; BLOOD GLUCOSE MONITORING; METABOLISM; METHODOLOGY; PATHOLOGY;

AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; FEMALE; HUMANS; INSULINOMA; NEOPLASM METASTASIS;

EID: 64749096517     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.7.880     Document Type: Article

References (8)

1. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma - incidence, recurrence, and longterm survival of patients: a 60-year study. Mayo Clin Proc. 1991;66:711-719.
2. Hirshberg B, Cochran C, Skarulis MC, et al. Malignant insulinoma: spectrum of unusual clinical features. Cancer. 2005;104:264-272.
3. Gill GV, Rauf O, MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgrad Med J. 1997;73:640-641.
4. Bode B, Gross K, Rikalo N, et al. Alarms based on realtime sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diabetes Technol Ther. 2004;6:105-113.
5. Monsod TP, Flanagan DE, Rife F, et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care. 2002;25:889-893.
6. Munir A, Choudhary P, Harrison B, Heller S, Newell-Price J. Continuous glucose monitoring in patients with insulinoma. Clin Endocrinol (Oxf). 2008;68:912-918.
7. Baldeweg S, Hope S, Tibbals J, Davidson B, Vanderpump M. Use of continuous glucose monitoring system in the medical management of insulinomas. Abstract presented at: Society for Endocrinology Annual Meeting; November 3-5, 2003; London, United Kingdom. Endocrine Abstracts, 6 DP23.
8. Wang X. Application of the Continuous Glucose Monitoring System (CGMS) in the 72-hour fast test in two patients with hypoglycemia. Diabetes Technol Ther. 2004;6:883-886.